Marex Group Limited

Report azionario NasdaqGS:MRX

Capitalizzazione di mercato: US$5.2b

Marex Group Salute del bilancio

Criteri Salute finanziaria verificati 2/6

Marex Group ha un patrimonio netto totale di $1.9B e un debito totale di $15.3B, che porta il suo rapporto debito/patrimonio netto a 819.6%. Le sue attività totali e le sue passività totali sono rispettivamente $42.1B e $40.3B.

Informazioni chiave

819.58%

Rapporto debito/patrimonio netto

US$15.32b

Debito

Indice di copertura degli interessin/a
ContantiUS$14.21b
Patrimonio nettoUS$1.87b
Totale passivitàUS$40.26b
Totale attivitàUS$42.13b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Seeking Alpha Aug 17

Recent Results From Marex Group Impress, But Some Risks Are Rising

Summary Marex Group delivered record H1 2026 revenue and profitability, with adjusted profit before tax of $318.6 million, driving an 18% stock surge on August 12. MRX's rapid acquisition strategy fueled significant YoY segment revenue growth, notably 134% in Market Making and 35% in Agency and Execution. Operational efficiency improved: adjusted profit margin rose 200 bps to 23%, and adjusted ROE reached 37.5%, nearly 700 bps higher YoY. Despite valuation concerns and increased risk from acquisitions and debt, I maintain a Buy rating on MRX given sustained earnings momentum. Read the full article on Seeking Alpha
Aggiornamento narrativa Aug 06

MRX: Rich Earnings Multiple Will Confront Weaker Revenue And Index Exclusion Risk

Analysts have raised their price target for Marex Group from about $37.00 to roughly $44.00, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News Marex Group completed the acquisition of European equity derivatives market maker Webb Traders, which focuses on single stock options for European and US mid and large cap equities.
Aggiornamento narrativa Jul 23

MRX: Bermuda Move And Digital Collateral Shift Will Constrain Upside Potential

Analysts have raised their price target for Marex Group from $59.75 to $72.38, citing updated assumptions around revenue contraction, profit margin, and future P/E that together support a higher fair value estimate. What’s in the News for Marex Group Marex Group is allowing derivatives clients to post USDC stablecoin as initial margin collateral using Coinbase infrastructure, following a December 2025 CFTC no action letter that permits futures commission merchants to accept certain digital assets as margin.
Aggiornamento narrativa Jul 08

MRX: Bermuda Redomiciliation Will Limit Future Upside From Current Levels

Analysts have nudged their price target for Marex Group higher from $57.13 to $59.75, citing updated assumptions that combine slightly softer revenue expectations with a small improvement in projected profit margins and a modestly higher future P/E multiple. What’s in the News for Marex Group Marex Group Limited completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, following shareholder approval on May 21, 2026, and English High Court sanction on June 26, 2026.
Aggiornamento narrativa Jun 22

MRX: Higher Fair Value And Market Volatility Tailwinds Will Support Upside

Analysts have raised their price target for Marex Group from $66.00 to $75.00, citing updated assumptions around revenue trends, a slightly higher discount rate, and modestly adjusted profit margin and P/E expectations. What’s in the News for Marex Group Night Watch Investment Management identified Marex Group plc as its largest holding, highlighting the futures clearing business as critical financial infrastructure with a strong and defensible market position, and pointing to earnings that have grown roughly 7x over the past five years, according to recent commentary from the firm.
Aggiornamento narrativa Jun 05

MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside

Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.
Aggiornamento narrativa May 22

MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside

Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).
Aggiornamento narrativa May 07

MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside

Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Aggiornamento narrativa Apr 22

MRX: Higher Fair Value And Lower Future P/E Will Support Upside

Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Aggiornamento narrativa Apr 07

MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook

Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.
Aggiornamento narrativa Mar 24

MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares

Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.
Aggiornamento narrativa Mar 09

MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside

Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.
Aggiornamento narrativa Feb 23

MRX: Rising Trading Volumes And Volatility Will Support Earnings Power

Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.
Aggiornamento narrativa Feb 07

MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward

The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.
Aggiornamento narrativa Jan 23

MRX: US Expansion And Higher Trading Volumes Will Support Future Upside

Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.
Aggiornamento narrativa Jan 08

MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim

Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.
Aggiornamento narrativa Dec 23

MRX Will Benefit From Expanding US Structured Products And Margin Resilience

Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.
Aggiornamento narrativa Dec 09

MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits

Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.
Aggiornamento narrativa Nov 25

MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk

Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.
Aggiornamento narrativa Nov 06

MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits

Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.
Aggiornamento narrativa Oct 23

Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook

Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.
Aggiornamento narrativa Oct 08

Digitalization And M&A Will Unlock Global Market Potential

Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
User avatar
Nuova narrativa Apr 27

Acquisitions Will Fuel APAC And Middle East Expansion

Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $40.6B ) di MRX superano le sue passività a breve termine ( $37.3B ).

Passività a lungo termine: Le attività a breve termine di MRX ( $40.6B ) superano le sue passività a lungo termine ( $2.9B ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 59% ) di MRX è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di MRX è aumentato da 240.1% a 819.6% negli ultimi 5 anni.

Copertura del debito: Il debito di MRX non è ben coperto dal flusso di cassa operativo ( 2.9% ).

Copertura degli interessi: Dati insufficienti per determinare se i pagamenti degli interessi sul debito di MRX siano ben coperti dall'EBIT.


Bilancio


Scoprire le aziende sane

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/08/18 09:07
Prezzo dell'azione a fine giornata2026/08/18 00:00
Utili2026/06/30
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Marex Group Limited è coperta da 11 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Benjamin BudishBarclays
Christopher AllenCitigroup Inc
Alexander BlosteinGoldman Sachs